Tg737 inhibition results in malignant transformation in fetal liver stem/progenitor cells by promoting cell-cycle progression and differentiation arrest

Molecular Carcinogenesis

Volumn 51, Issue 8, 2012, Pages 659-673

  You, Nan ^a   Liu, Weihui ^a   Zhong, Xiao ^b   Ji, Ru ^a   Zhang, Ming ^a   You, Houcheng ^c   Dou, Kefeng ^a   Tao, Kaishan ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c AFFILIATED HOSPITAL OF NORTH SICHUAN MEDICAL COLLEGE   (China)

Author keywords

Cell cycle; Differentiation arrest; Fetal liver stem progenitor cells (FLSPCs); Malignant transformation; Tg737

Indexed keywords

ALBUMIN; ALPHA FETOPROTEIN; CELL MARKER; CYCLIN B; CYCLIN D1; MESSENGER RNA; SHORT HAIRPIN RNA;

ANIMAL CELL; APOPTOSIS; ARTICLE; ASSAY; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELL STRUCTURE; CELL ULTRASTRUCTURE; EMBRYO; FETAL LIVER STEM CELL; FETAL STEM CELL; FETUS; GENE SILENCING; IMMUNOCYTOCHEMISTRY; LIVER CARCINOGENESIS; MALIGNANT TRANSFORMATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; RAT; RNA INTERFERENCE; TUMOR SUPPRESSOR GENE; TUMOR SUPPRESSOR GENE TG737; UPREGULATION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE CHECKPOINTS; CELL DIFFERENTIATION; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; FEMALE; FETAL STEM CELLS; LIVER; MICE; MICE, NUDE; MICROSCOPY, ELECTRON, TRANSMISSION; NEOPLASMS, EXPERIMENTAL; RATS; RATS, INBRED F344; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSPLANTATION, HETEROLOGOUS; TUMOR SUPPRESSOR PROTEINS;

MUS;

EID: 84863469761     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20839     Document Type: Article

References (50)

1. Lin H, van den Esschert J, Liu C, van Gulik TM. Systematic review of hepatocellular adenoma in China and other regions. J Gastroenterol Hepatol 2011; 26: 28-35.
2. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362: 1907-1917.
3. Papoulas M, Theocharis S. Primary liver tumors: Origin and target therapy. Expert Opin Ther Targets 2009; 13: 957-965.
4. Zhu Z, Hao X, Yan M, et al. Cancer stem/progenitor cells are highly enriched in CD133+CD44+ population in hepatocellular carcinoma. Int J Cancer 2010; 126: 2067-2078.
5. Yao Z, Mishra L. Cancer stem cells and hepatocellular carcinoma. Cancer Biol Ther 2009; 8: 1691-1698.
6. Oliva J, French BA, Qing X, French SW. The identification of stem cells in human liver diseases and hepatocellular carcinoma. Exp Mol Pathol 2010; 88: 331-340.
7. Navarro-Alvarez N, Soto-Gutierrez A, Kobayashi N. Hepatic stem cells and liver development. Methods Mol Biol 2010; 640: 181-236.
8. Peng N, Li L, Cai X, Tan S, Wu T. Liver stem/progenitor cells in the canals of Hering: Cellular origin of hepatocellular carcinoma with bile duct tumor thrombi? Stem Cell Rev 2010; 6: 579-584.
9. Zucman-Rossi J. Molecular classification of hepatocellular carcinoma. Dig Liver Dis 2010; 42: S235-S241.
10. Gouas DA, Shi H, Hautefeuille AH, et al. Effects of the TP53p. R249S mutant on proliferation and clonogenic properties in human hepatocellular carcinoma cell lines: Interaction with hepatitis B virus X protein. Carcinogenesis 2010; 31: 1475-1482.
11. Isfort RJ, Cody DB, Doersen CJ, et al. The tetratricopeptide repeat containing Tg737 gene is a liver neoplasia tumor suppressor gene. Oncogene 1997; 15: 1797-1803.
12. Robert A, Margall-Ducos G, Guidotti JE, et al. The intraflagellar transport component IFT88/polaris is a centrosomal protein regulating G1-S transition in non-ciliated cells. J Cell Sci 2007; 120: 628-637.
13. Song Z, Li R, You N, Tao K, Dou K. Loss of heterozygosity of the tumor suppressor gene Tg737 in the side population cells of hepatocellular carcinomas is associated with poor prognosis. Mol Biol Rep 2010; 37: 4091-4101.
14. Liu WH, Li R, Dou KF. Convenient and efficient enrichment of the CD133+ liver cells from rat fetal liver cells as a source of liver stem/progenitor cells. Stem Cell Rev 2011; 7: 94-102.
15. Zucman-Rossi J, Laurent-Puig P. Genetic diversity of hepatocellular carcinomas and its potential impact on targeted therapies. Pharmacogenomics 2007; 8: 997-1003.
16. Midorikawa Y, Sugiyama Y, Aburatani H. Molecular targets for liver cancer therapy: From screening of target genes to clinical trials. Hepatol Res 2009; 40: 49-60.
17. Li T, Wan B, Huang J, Zhang X. Comparison of gene expression in hepatocellular carcinoma, liver development, and liver regeneration. Mol Genet Genomics 2010; 283: 485-492.
18. Nejak-Bowen KN, Monga SP. Beta-catenin signaling, liver regeneration and hepatocellular cancer: Sorting the good from the bad. Semin Cancer Biol 2011; 21: 44-58.
19. Kato T, Miyamoto M, Date T, et al. Repeated hepatocyte injury promotes hepatic tumorigenesis in hepatitis C virus transgenic mice. Cancer Sci 2003; 94: 679-685.
20. Teufel A, Galle PR. Collecting evidence for a stem cell hypothesis in HCC. Gut 2010; 59: 870-871.
21. Wu XZ, Chen D. Origin of hepatocellular carcinoma: Role of stem cells. J Gastroenterol Hepatol 2006; 21: 1093-1098.
22. Chiba T, Kita K, Zheng YW, et al. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Hepatology 2006; 44: 240-251.
23. Kitisin K, Shetty K, Mishra L, Johnson LB. Hepatocellular stem cells. Cancer Biomark 2007; 3: 251-262.
24. Alison MR. Liver stem cells: Implications for hepatocarcinogenesis. Stem Cell Rev 2005; 1: 253-260.
25. Houghton J, Stoicov C, Nomura S, et al. Gastric cancer originating from bone marrow-derived cells. Science 2004; 306: 1568-1571.
26. Welm AL, Kim S, Welm BE, Bishop JM. MET and MYC cooperate in mammary tumorigenesis. Proc Natl Acad Sci USA 2005; 102: 4324-4329.
27. El Wakil A, Lalli E. The Wnt/beta-catenin pathway in adrenocortical development and cancer. Mol Cell Endocrinol 2011; 332: 32-37.
28. Jain P, Alahari SK. Breast cancer stem cells: A new challenge for breast cancer treatment. Front Biosci 2011; 16: 1824-1832.
29. Takebe N, Harris PJ, Warren RQ, Ivy SP. Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways. Nat Rev Clin Oncol 2011; 8: 97-106.
30. Tang B, Yoo N, Vu M, et al. Transforming growth factor-beta can suppress tumorigenesis through effects on the putative cancer stem or early progenitor cell and committed progeny in a breast cancer xenograft model. Cancer Res 2007; 67: 8643-8652.
31. Incassati A, Chandramouli A, Eelkema R, Cowin P. Key signaling nodes in mammary gland development and cancer: Beta-catenin. Breast Cancer Res 2010; 12: 213.
32. Zhao X, Malhotra GK, Lele SM, et al. Telomerase-immortalized human mammary stem/progenitor cells with ability to self-renew and differentiate. Proc Natl Acad Sci USA 2010; 107: 14146-14151.
33. Boyer MJ, Cheng T. The CDK inhibitors: Potential targets for therapeutic stem cell manipulations? Gene Ther 2008; 15: 117-125.
34. Lieu YK, Reddy EP. Conditional c-myb knockout in adult hematopoietic stem cells leads to loss of self-renewal due to impaired proliferation and accelerated differentiation. Proc Natl Acad Sci USA 2009; 106: 21689-21694.
35. Rothenberg ME, Clarke MF, Diehn M. The Myc connection: ES cells and cancer. Cell 2010; 143: 184-186.
36. Steiner D, Khaner H, Cohen M, et al. Derivation, propagation and controlled differentiation of human embryonic stem cells in suspension. Nat Biotechnol 2010; 28: 361-364.
37. Teoh NC. Proliferative drive and liver carcinogenesis: Too much of a good thing? J Gastroenterol Hepatol 2009; 24: 1817-1825.
38. Kaufmann WK, Kaufman DG. Cell cycle control, DNA repair and initiation of carcinogenesis. FASEB J 1993; 7: 1188-1191.
39. Butt AJ, Caldon CE, McNeil CM, Swarbrick A, Musgrove EA, Sutherland RL. Cell cycle machinery: Links with genesis and treatment of breast cancer. Adv Exp Med Biol 2008; 630: 189-205.
40. Yu X, Si J, Zhang Y, Dewille JW. CCAAT/enhancer binding protein-delta (C/EBP-delta) regulates cell growth, migration and differentiation. Cancer Cell Int 2010; 10: 48.
41. Wang T, Hao L, Feng Y, Wang G, Qin D, Gu G. Knockdown of MED19 by lentivirus-mediated shRNA in human osteosarcoma cells inhibits cell proliferation by inducing cell cycle arrest in the G0/G1 phase. Oncol Res 2011; 19: 193-201.
42. Jirmanova L, Afanassieff M, Gobert-Gosse S, Markossian S, Savatier P. Differential contributions of ERK and PI3-kinase to the regulation of cyclin D1 expression and to the control of the G1/S transition in mouse embryonic stem cells. Oncogene 2002; 21: 5515-5528.
43. Jia KZ, Tang B, Yu L, et al. Adenosine induces G2/M cell-cycle arrest by inhibiting cell mitosis progression. Cell Biol Int 2009; 34: 49-52.
44. Zhong XG, He S, Yin W, Deng JY, Cheng B. Selective tropism of liver stem cells to hepatocellular carcinoma in vivo. World J Gastroenterol 2007; 13: 3886-3891.
45. Lee TK, Castilho A, Ma S, Ng IO. Liver cancer stem cells: Implications for a new therapeutic target. Liver Int 2009; 29: 955-965.
46. Guise T. Examining the metastatic niche: Targeting the microenvironment. Semin Oncol 2010; 37: S2-S14.
47. Burness ML, Sipkins DA. The stem cell niche in health and malignancy. Semin Cancer Biol 2010; 20: 107-115.
48. Sottoriva A, Sloot PM, Medema JP, Vermeulen L. Exploring cancer stem cell niche directed tumor growth. Cell Cycle 2010; 9: 1472-1479.
49. Chiba T, Zheng YW, Kita K, et al. Enhanced self-renewal capability in hepatic stem/progenitor cells drives cancer initiation. Gastroenterology 2007; 133: 937-950.
50. Chiba T, Seki A, Aoki R, et al. Bmi1 promotes hepatic stem cell expansion and tumorigenicity in both Ink4a/Arf-dependent and -independent manners in mice. Hepatology 2010; 52: 1111-1123.